--- title: "DELCATH SYSTEMS, INC. (DCTH) stock and investor profile" url: "https://aibio.space/companies/delcath-systems/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "DELCATH SYSTEMS, INC. (NASDAQ: DCTH), United States. Listing facts, related biotech companies and news on aibio.space." --- DCTH DELCATH SYSTEMS, INC. NASDAQ · United States # DELCATH SYSTEMS, INC. (DCTH) news DELCATH SYSTEMS, INC. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker DCTH, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest DELCATH SYSTEMS, INC. news We have not published a story on DELCATH SYSTEMS, INC. yet. When there is news, it will appear here. ## DELCATH SYSTEMS, INC. at a glance - **Ticker**: DCTH - **Listing**: NASDAQ - **Country**: United States - **Cash, Jun 30, 2026**: $95.9 million ### Related companies - [Bespoke Extracts](https://aibio.space/companies/bespoke-extracts/) OTC: BSPK - [ADM TRONICS UNLIMITED, INC.](https://aibio.space/companies/adm-tronics-unlimited/) OTC: ADMT - [MiniMed Group](https://aibio.space/companies/minimed/) NASDAQ: MMED - [Medpace Holdings](https://aibio.space/companies/medpace/) NASDAQ: MEDP - [Hyperfine](https://aibio.space/companies/hyperfine/) NASDAQ: HYPR - [VOLITIONRX LTD](https://aibio.space/companies/volitionrx/) NYSE: VNRX - [iRhythm Holdings](https://aibio.space/companies/irhythm/) NASDAQ: IRTC - [GRAIL](https://aibio.space/companies/grail/) NASDAQ: GRAL ### Also on NASDAQ - [Nurix Therapeutics](https://aibio.space/companies/nurix-therapeutics/) NRIX - [Oric Pharmaceuticals](https://aibio.space/companies/oric-pharmaceuticals/) ORIC - [Sunshine Biopharma](https://aibio.space/companies/sunshine-biopharma/) SBFM - [Alvotech](https://aibio.space/companies/alvotech/) ALVO - [BioCryst Pharmaceuticals](https://aibio.space/companies/biocryst-pharmaceuticals/) BCRX - [Arvinas](https://aibio.space/companies/arvinas/) ARVN ## DELCATH SYSTEMS, INC. annual financials | Line | FY2025 | FY2024 | |---|---|---| | Revenue | [$85.2 million](https://www.sec.gov/Archives/edgar/data/872912/000162828026012019/) | [$37.2 million](https://www.sec.gov/Archives/edgar/data/872912/000162828026012019/) | | Research and development | [$29.2 million](https://www.sec.gov/Archives/edgar/data/872912/000162828026012019/) | [$13.9 million](https://www.sec.gov/Archives/edgar/data/872912/000162828026012019/) | | Net income (loss) | [$2.7 million](https://www.sec.gov/Archives/edgar/data/872912/000162828026012019/) | [-$26.4 million](https://www.sec.gov/Archives/edgar/data/872912/000162828026012019/) | | Cash from operations | [$22.5 million](https://www.sec.gov/Archives/edgar/data/872912/000162828026012019/) | [-$18.7 million](https://www.sec.gov/Archives/edgar/data/872912/000162828026012019/) | | Cash and equivalents | [$43.5 million](https://www.sec.gov/Archives/edgar/data/872912/000162828026053956/) | [$32.4 million](https://www.sec.gov/Archives/edgar/data/872912/000162828026012019/) | | Short-term investments | [$47.6 million](https://www.sec.gov/Archives/edgar/data/872912/000162828026053956/) | [$20.8 million](https://www.sec.gov/Archives/edgar/data/872912/000162828026012019/) | Latest balance sheet, Jun 30, 2026 (10-Q): cash and equivalents $47.5 million, plus short-term investments of $48.4 million, $95.9 million in all. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about DELCATH SYSTEMS, INC. What is the ticker symbol of DELCATH SYSTEMS, INC.? DELCATH SYSTEMS, INC. trades under the ticker DCTH on NASDAQ. Where is DELCATH SYSTEMS, INC. listed? DELCATH SYSTEMS, INC. is listed on NASDAQ. Which country or territory is DELCATH SYSTEMS, INC. listed under? Our directory records DELCATH SYSTEMS, INC. under United States. Does aibio.space cover DELCATH SYSTEMS, INC.? aibio.space lists DELCATH SYSTEMS, INC. among 2,820 public biotech companies and publishes its news here as stories appear. What was DELCATH SYSTEMS, INC.'s revenue last year? $85.2 million for the fiscal year ended Dec 31, 2025, as reported to the SEC. Is DELCATH SYSTEMS, INC. profitable? DELCATH SYSTEMS, INC. reported net income of $2.7 million for the fiscal year ended Dec 31, 2025, and generated $22.5 million of cash from operations, per its annual report to the SEC. How much does DELCATH SYSTEMS, INC. spend on research and development? $29.2 million in the fiscal year ended Dec 31, 2025, per its annual report. How much cash does DELCATH SYSTEMS, INC. have? $95.9 million in cash and short-term investments at Jun 30, 2026, per its 10-Q. ## Investor discussion: DELCATH SYSTEMS, INC. Members talk about DELCATH SYSTEMS, INC. (DCTH). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NASDAQ:DCTH on TradingView](https://www.tradingview.com/symbols/NASDAQ-DCTH/). ## Listing details DELCATH SYSTEMS, INC. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker DCTH, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: DELCATH SYSTEMS, INC. - **Ticker**: DCTH - **Listing**: NASDAQ - **Country or territory**: United States Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/delcath-systems/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "DELCATH SYSTEMS, INC. (DCTH) stock and investor profile", 2026-10-31, https://aibio.space/companies/delcath-systems/